Pubdate: Mon, 05 Feb 2007 Source: Herald Sun (Australia) Copyright: 2007 Herald and Weekly Times Contact: http://www.heraldsun.news.com.au/ Details: http://www.mapinc.org/media/187 Author: Jane Metlikovec, health reporter Bookmark: http://www.mapinc.org/heroin.htm (Heroin) IMPLANTS FAIL TO STOP OVERDOSE AN implant designed to help heroin addicts kick their habit could contribute to their deaths. A National Drug and Alcohol Research Centre study has identified five deaths of Australians with naltrexone implants from 2000 to 2004. Two of the victims had high levels of the opioid suppressant in their system when they died. Naltrexone implants were introduced in Australia 10 years ago for heroin addicts who were forgetting to take their daily dose of the drug. About 1000 Australians have a naltrexone implant, which is usually a capsule inserted under the skin of their stomach. The study, published in the Medical Journal of Australia yesterday, is the first proof that addicts can still have an overdose and die while implanted with the drug. Report author Amy Gibson said some addicts had overdosed on heroin while trying to override the power of the implant, which blocks the effect of heroin on the brain. "There is the impression out there that the implant is a bit of a magic cure, that it will block everything and make it impossible to die," Ms Gibson said. "We've shown that that's not the case." Ms Gibson said her research also highlighted the risk of a combined drug effect with naltrexone. Of the five deaths, a male and a female died while undergoing naltrexone implant treatment, another male died two weeks after having an implant removed, and the other two males died six months after having an implant inserted. An autopsy on the male who was undergoing implant treatment at the time of his death showed elevated levels of heroin and much higher levels of naltrexone than was needed to block the drug. Naltrexone was recorded by a coroner as playing a causal role in the death of the woman. She also had methamphetamine in her system. The woman had experienced strong pain from the implant site in her stomach two days before her death. The other three died from drug cocktails consisting of heroin and anti-anxiety drug diazepam. One of the males also recorded a reading for codeine (used to relieve pain) and another had alcohol in his system. Ms Gibson said it was important for doctors to tell naltrexone patients about the risk of overdose. A spokesman for naltrexone supplier Bristol-Myers Squibb said the company sold the drug as a tablet only and could not comment on implant use. - - with AAP - --- MAP posted-by: Beth Wehrman